An open-label, single-dose, randomized, 2-period, crossover, bioequivalence study to compare levonorgestrel 90 mg/ethinyl estradiol 20 mg in 2 dosage forms with different dissolution characteristics in healthy, cycling women

Trial Profile

An open-label, single-dose, randomized, 2-period, crossover, bioequivalence study to compare levonorgestrel 90 mg/ethinyl estradiol 20 mg in 2 dosage forms with different dissolution characteristics in healthy, cycling women

Withdrawn prior to enrolment
Phase of Trial: Phase I

Latest Information Update: 23 Aug 2010

At a glance

  • Drugs Ethinylestradiol/levonorgestrel (Primary)
  • Indications Pregnancy
  • Focus Pharmacokinetics
  • Sponsors Wyeth
  • Most Recent Events

    • 21 Jul 2009 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
    • 05 May 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top